在孤立的长期激活的部分血栓塑时间的工作过程中发现罕见的prekallikrein缺乏症
Jennifer S Woo1, Jennifer Tseng2, Irene M Kang3
1Department of Pathology, City of Hope National Medical Center, Irvine, CA.
Ochsner journal
|December 25, 2024
概括
延长激活部分血栓形成时间 (aPTT) 可能表明存在严重问题,但接触因子缺乏症,如前卡利克林缺乏症,不会增加出血风险. 识别这些罕见的原因对于准确的出血风险评估至关重要.
科学领域:
- 血液学 血液学 血液学
- 临床病理学 临床病理学
背景情况:
- 延长的激活部分血栓形成时间 (aPTT) 可能表明凝血因子缺乏或抑制剂,可能表明出血风险.
- 接触因子缺陷 (XII因子,前卡利克林,HMWK) 也延长了aPTT,但与临床出血无关.
研究的目的:
- 报告因前卡利克林缺乏症而导致的孤立长期aPTT病例.
- 突出调查长期aPTT的罕见原因的重要性,以准确评估出血风险.
主要方法:
- 最初的凝血查测试,包括因子测试和狼抗凝剂/抗脂抗体测试.
- 混合研究,以调查疑似因子缺乏症.
- 接触因子活动测试,以确定特定的接触因子缺陷.
主要成果:
- 一名71岁的女性出现了孤立的长期aPTT.
- 标准测试排除了常见的因子缺陷和抑制剂.
- 混合研究表明因子缺乏,导致接触因子测试.
- 这位患者被诊断出患有前蛋白缺乏症.
结论:
- 接触因子缺乏症,如前卡利克林缺乏症,是孤立长期aPTT的罕见原因.
- 识别接触因子缺陷对于正确评估患者出血风险至关重要.
- 这个案例说明了诊断孤立长期aPTT的现代方法.
更多相关视频
相关概念视频
Disorders of Hemostasis
638
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
638
Anticoagulant Drugs: Low-Molecular-Weight Heparins
532
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
532
Extrinsic and Intrinsic Pathways of Hemostasis
3.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
3.5K
Formation of the Platelet Plug
2.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
2.7K
Clot Retraction and Fibrinolysis
2.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
2.4K
Coagulation
3.1K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
3.1K


